Sort
261,768 grants matching “gene therapy”
UCLA IDDRC
$1,241,552Susan Y Bookheimer · University Of California Los Angeles · P50 · FY2020 · HD
UCLA IDDRC
$1,241,552Susan Y Bookheimer · University Of California Los Angeles · P50 · FY2023 · HD
UCLA IDDRC
$1,241,552Susan Y Bookheimer · University Of California Los Angeles · P50 · FY2021 · HD
UCLA IDDRC
$1,241,552Susan Y Bookheimer · University Of California Los Angeles · P50 · FY2024 · HD
COMPREHENSIVE SICKLE CELL CENTER
$1,241,428University Of Southern California · P60 · FY2002 · HL
TempO-LINC high throughput high sensitivity single cell gene expression profiling assay Ph II
$1,241,285Bruce E. Seligmann · Biospyder Technologies, Inc. · R44 · FY2023 · GM
Microenvironmental control of progenitors in organ dysfunction and repair
$1,241,255Jay W Schneider · Ut Southwestern Medical Center · U01 · FY2015 · HL
Biospecimen Unit
$1,241,085Bruce E. Johnson · Dana-Farber Cancer Inst · U2C · FY2023 · CA
Development of Recombinant Toxins to Treat Hematologic Malignancies
$1,241,003Robert Kreitman · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Enhancing immunity to malaria in young children with effective chemoprevention
$1,240,701Prasanna Jagannathan · Stanford University · U01 · FY2022 · AI
Novel Strategies for Brain Tumor Therapy
$1,240,698Ian F. Pollack · University Of Pittsburgh At Pittsburgh · P01 · FY2008 · NS
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
$1,240,655Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Impact of sex differences on the trajectory of interactome dysfunctions across the AD spectrum
$1,240,570Gabriela Chiosis · Sloan-Kettering Inst Can Research · R01 · FY2021 · AG
NHGRI/DIR Technology Transfer Program
$1,240,530Eric Green · National Human Genome Research Institute · Z01 · FY2008 · HG
Environmental Exposure and DNA Damage
$1,240,488Jack A Taylor · National Institute Of Environmental Health Sciences · ZIA · FY2019 · ES
MIND Institute Intellectual and Developmental Disabilities Research Center
$1,240,447Leonard J Abbeduto · University Of California At Davis · U54 · FY2019 · HD
MIND Institute Intellectual and Developmental Disabilities Research Center
$1,240,447Leonard J Abbeduto · University Of California At Davis · U54 · FY2017 · HD
CREATION AND CHARACTERIZATION OF MOUSE MODELS OF HUMAN L
$1,240,360Massachusetts Institute Of Technology · U01 · FY2003 · CA
Cancer Biology and Genetics
$1,240,285Harold Varmus · National Human Genome Research Institute · ZIA · FY2013 · HG
Development of Recombinant Toxins to Treat Hematologic Malignancies
$1,240,277Robert Kreitman · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer
$1,240,024Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Enhancing immunity to malaria in young children with effective chemoprevention
$1,240,005Prasanna Jagannathan · Stanford University · U01 · FY2024 · AI
Phase II- Repurposing CRH antagonists for the treatment of endometriosis
$1,239,987Annelyn Torres-Reveron · Sur180 Therapeutics, Llc · R44 · FY2025 · HD
Pharmacogenomics of Immune Suppressants in Kidney Transplantation
$1,239,887Pamala A Jacobson · University Of Minnesota · U19 · FY2014 · AI
PROgenitor cell release Plus Exercise to improve functional performance in PAD
$1,239,870Mary McGrae McDermott · Northwestern University At Chicago · R01 · FY2012 · HL